Terms: = Germ cell tumor AND MSN, P26038, 4478, ENSG00000147065 AND Prognosis
9 results:
1. Application of a risk score model based on glycosylation-related genes in the prognosis and treatment of patients with low-grade glioma.
Zou B; Li M; Zhang J; Gao Y; Huo X; Li J; Fan Y; Guo Y; Liu X
Front Immunol; 2024; 15():1467858. PubMed ID: 39445005
[TBL] [Abstract] [Full Text] [Related]
2. Response rate specific to bone metastasis of various cancers for immune checkpoint inhibitors: a systematic review.
Tsukamoto S; Mavrogenis AF; Masunaga T; Aiba H; Aso A; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Eur J Orthop Surg Traumatol; 2024 Aug; 34(6):2823-2833. PubMed ID: 38836904
[TBL] [Abstract] [Full Text] [Related]
3. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Neural Progenitor cell-associated Chemoradiotherapy Resistance Gene Set (
Yang Y; Xu X; Xie Y; Liu Y; Ning C; Ai Y; Lv C; Wei H; Ge X; Yi T; Piao Y; Wang X; Jin X
Curr Pharm Des; 2022; 28(26):2189-2202. PubMed ID: 35718975
[TBL] [Abstract] [Full Text] [Related]
5. Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin.
Massone C; Hofman-Wellenhof R; Chiodi S; Sola S
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440462
[TBL] [Abstract] [Full Text] [Related]
6. Identification of purity and prognosis-related gene signature by network analysis and survival analysis in brain lower grade glioma.
Xiong Z; Xiong Y; Liu H; Li C; Li X
J Cell Mol Med; 2020 Oct; 24(19):11607-11612. PubMed ID: 32869484
[TBL] [Abstract] [Full Text] [Related]
7. Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme.
Yu X; Feng L; Liu D; Zhang L; Wu B; Jiang W; Han Z; Cheng S
Oncotarget; 2016 Mar; 7(12):14161-71. PubMed ID: 26895104
[TBL] [Abstract] [Full Text] [Related]
8. Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.
Anderton JA; Lindsey JC; Lusher ME; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
Neuro Oncol; 2008 Dec; 10(6):981-94. PubMed ID: 18664619
[TBL] [Abstract] [Full Text] [Related]
9. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
[TBL] [Abstract] [Full Text] [Related]